In response to drug-resistant “superbugs” that send millions of people to hospitals around the world, scientists are building tiny, “molecular drill bits” that kill bacteria by bursting through their protective cell walls.
They presented some of the latest developments on these drill bits, better known to scientists as antimicrobial peptides (AMPs), at the 247th National Meeting & Exposition of the American Chemical Society (ACS), the world’s largest scientific society.
The meeting, which features more than 10,000 scientific reports across disciplines from energy to medicine, continues here through Thursday.
One of the researchers in the search for new ways to beat pathogenic bacteria is Georges Belfort, Ph.D. He and his team have been searching for a new therapy against the bacteria that cause tuberculosis (TB). It’s a well-known, treatable disease, but resistant strains are cropping up. The World Health Organization estimates that about 170,000 people died from multidrug-resistant TB in 2012.
“If the bacteria build resistance to all current treatments, you’re dead in the water,” said Belfort, who is at Rensselaer Polytechnic Institute.
To avoid this dire scenario, scientists are developing creative ways to battle the disease. In ongoing research, Belfort’s group together with his wife, Marlene Belfort, and her group at the University at Albany are trying to dismantle bacteria from within. They also decided to attack it from the outside.
In their search for a way to do this, they came upon AMPs. Although these naturally occurring, short strings of amino acids are not new — all classes of organisms from humans to bacteria produce them as part of their natural defense strategy — the fight against drug-resistant pathogens has heightened attention on these protective molecules.
Researchers began studying them in earnest in the 1980s. By 2010, they had identified nearly 1,000 unique AMPs from many sources, including fly larvae, frog skin and mammalian immune system cells. The molecules come in different shapes, lengths and with other varying traits. But one thing they all have in common is that they somehow break through bacterial cell walls, the tough outer layers that provide structural support and protection. When Belfort found out about AMPs’ mode of action, he aptly dubbed them “molecular drill bits.”
Intrigued by their potential, Belfort scoured recent work on the peptides and discovered a database filtering technique developed by another group, reported in 2012. It’s a kind of design-your-own-AMP model.
Using the database filtering technology, Belfort’s lab designed and synthesized three novel AMPs designed to drill into the thick walls of tuberculosis cells. When they tested them in the lab against Mycobacterium tuberculosis and another similar bacteria, all three AMPs killed the bacteria. One worked better than the others — but not as well as kanamycin, which is one of several antibiotics in the arsenal against TB that some strains have developed resistance against.
Belfort’s team is now focused on improving their designs and understanding exactly how AMPs work. The group is also developing a laboratory test that will allow them to tell within hours rather than weeks if an AMP is working against Mycobacterium tuberculosis.
If developed into pharmaceuticals, AMPs could have the additional benefit of overcoming the very challenge they’re designed to meet: drug-resistance. AMPs attack bacteria’s walls, or cell membranes, which have been conserved through a long history of evolution.
“It’s going to be much more difficult for a bacterium that’s been around for millions of years to reconfigure its membrane,” Belfort said. “That’s the core protective structure that has helped it survive this long.”
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- A dose response model for quantifying the infection risk of antibiotic-resistant bacteriaon November 19, 2019 at 8:37 am
However, risk quantification for antibiotic-resistant bacteria (ARB) has been hindered by the absence of suitable DRMs for ARB. A new approach to DRMs is introduced to capture ARB and ...
- Italy top in EU in antibiotic-resistanceon November 19, 2019 at 8:11 am
(ANSA) - Rome, November 19 - Italy is top in the European Union for antibiotic-resistance deaths with over 10,000 of the 33,000 deaths in the EU each year caused by bacteria resistant to antibiotics, ...
- OpGen Products in Development to Address "Urgent Threat" Pathogens Highlighted in New CDC Report on Antibiotic Resistance Threatson November 19, 2019 at 3:30 am
Nov. 19, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. OPGN, -2.53% announced today that the Center for Disease Control (CDC) has released updated data increasing the number of deaths in the United States (U.S ...
- Health officials warn of antibiotic-resistant 'superbugs'on November 18, 2019 at 7:32 pm
Health officials are spreading the word: Lay off the antibiotics when possible, to avoid fueling the spread of antibiotic-resistant “superbugs.” The North Dakota Department of Health, echoing health ...
- PipelineRx Launches Comprehensive Antimicrobial Stewardship Solution, Helping Combat Antibiotic Resistanceon November 18, 2019 at 4:09 pm
The cloud-based solutions, unveiled during Antibiotic Awareness Week, are intended to help combat antibiotic resistant bacteria and the rise of superbugs through monitoring, counseling, intervention ...
- CDC expert: 'Antibiotic resistance is worse than we previously thought'on November 18, 2019 at 10:38 am
A superbug, otherwise known as an antibiotic-resistant infection, can be potentially lethal. And according to a new CDC report, there are more than 2.8 million superbugs in the U.S. each year, with ...
- The rise of superbugs: Facing the antibiotic resistance crisison November 18, 2019 at 9:05 am
While medical research has helped us overcome many health threats, we now face a new type of crisis: Many dangerous bacteria are becoming resistant to the drugs meant to fight them. Where do we go ...
- Antibiotic Resistance: Rise Of Bacteria That Are Resistant To Antibiotics Alarms Medical Practitionerson November 18, 2019 at 3:10 am
Antibiotic resistance seems to create a growing problem among medical practitioners all over the world. Ailments that were once easy to treat have become unmanageable. Doctors explain that bacteria ...
- CDC Report Finds 35,000 Americans Die of Antibiotic-Resistant Infections Each Yearon November 15, 2019 at 10:19 am
An estimated 35,000 Americans die of antibiotic-resistant infections each year—one every 15 minutes—according to a stark new report from the Centers of Disease Control and Prevention that reveals that ...
- Antibiotic-resistant infections are deadlier than before. Here are 5 things to knowon November 14, 2019 at 10:40 am
Antibiotic-resistant infections are a bigger threat than previously thought, according to a new report from the Centers for Disease Control and Prevention. The report, Antibiotic Resistance Threats in ...
via Bing News